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ABSTRACT We examined the activation of transcription
from the human immunodeficiency virus type 1 (HIV-1) pro-
moter by the viral Tat protein in a transient expression system.
Plasmids contained a HIV-reporter gene cassette and a simian
virus 40 origin ofDNA replication. Run-on assays of transcrip-
tion complex distribution and analysis of cytoplasmic RNA
accumulation confirmed that Tat is able to activate transcrip-
tion by two mechanisms: by increasing the rate of transcrip-
tional initiation and the efficiency of transcriptional elongation.
The degree to which Tat stimulated initiation is determined by
the basal level of HIV-directed transcription, which is influ-
enced by the position of the simian virus 40 replication orwin.
Tat functions primarily to increase the efficiency of elongation
when the origin is located downstream from the HIV-reporter
cassette and the basal level oftranscription is high. On the other
hand, Tat functions primarily to increase the rate of initiation
when the origin is upstream from the cassette and the basal
level oftranscription is 10-fold lower. These studies suggest that
the site of integration of the virus into the cellular genome may
significantly affect the level of expression from the H1V pro-
moter and consequently the pathobiology of the virus.
The human immunodeficiency virus type 1 (HIV-1) Tat
protein is a potent transactivator of HIV-1 gene expression
and plays an essential role in the infectious process of the
virus (1, 2), but its mechanism of action has not been fully
resolved. It has been-proposed that Tat functions at a number
of different levels, including transcriptional initiation, elon-
gation of nascent RNA chains, posttranscriptional process-
ing, and protein synthesis (reviewed in ref. 3). The target for
Tat-mediated transactivation is a sequence within the R
region of the long terminal repeat (LTR) designated the
trans-acting responsive element (TAR), minimally, residues
+14 to +44 relative to the transcriptional initiation site (4-8).
The TAR element must be situated near the transcription
start site in the correct orientation (7). Tat interacts with
RNA transcribed from the TAR region, which forms a bulged
stem-loop structure (9), and recent work suggests that TAR
functions largely, if not exclusively, to draw Tat to the
vicinity of the transcription start site (10-12).
Studies of Tat's effect on transcription have typically
employed model systems in which LTR-directed transcrip-
tion of a reporter gene, generally the chloramphenicol ace-
tyltransferase (CAT) gene, is compared in the presence and
absence of Tat. Run-on transcription analysis revealed that
Tat modulates reporter gene expression by increasing the rate
of transcription from the HIV LTR. This conclusion is drawn
from transient expression assays, in which the reporter gene
was transfected into cells as plasmid DNA (4, 13-16), and
from infection assays, in which the reporter gene was deliv-
ered via an adenovirus vector (17, 18). Further analysis of
transcription complex distribution in a transient expression
system suggested that Tat modulates LTR-directed transcrip-
tion by relieving a block to transcriptional elongation in the
TAR region (14). In this study, the transcription complexes
were determined to be distributed equally between the pro-
moter proximal region [339 nucleotides (nt)] and the adjacent
region (520 nt) in the presence of Tat. In the absence of Tat,
however, the density of transcription complexes was un-
changed in the promoter proximal region, but no complexes
were detected in the promoter distal region. A similar study
conducted in our laboratory using the adenovirus system
reached somewhat different conclusions (19). When tran-
scription complex distribution was examined over short
intervals within the promoter proximal region, most com-
plexes were observed within the immediately promoter-
proximal region (23 or 83 nt) when transcription was carried
out in the absence of Tat. Tat affected transcription in two
ways: it increased the efficiency of transcriptional elongation
by suppressing polarity, and it also increased the rate of
transcriptional initiation at the HIV promoter.
To resolve the differences between these two studies we
examined transcription from the HIV-1 LTR in the transient
expression system. We found that the basal transcription rate
is the determinative feature and that this is influenced by the
structure of the template, in particular by the location of the
simian virus 40 (SV40) replication origin. Placement of the
origin region downstream from the HIV LTR-CAT cassette
permitted 10-fold more transcription from the LTR than when
the origin was placed upstream from the LTR. When the
origin was in the upstream location, Tat increased both the
rate of initiation and the efficiency of elongation; on the other
hand, when the origin was downstream Tat primarily func-
tioned to increase the efficiency of transcriptional elongation.
We infer that Tat can stimulate both processes but the
increase in initiation is apparent only when the basal level of
LTR-directed transcription is low.
MATERIALS AND METHODS
Plasmid and Probe Construction. The structures of the
LTR-CAT plasmids are diagramed in Fig. 1. Plasmid pHi
contains the Xho I-BamHI fragment of pU3RIII (20) flanked
by Xba I linkers and cloned into pUC19. The SV40 origin of
replication (SV40 fragment nt 5171-128) was inserted between
the polylinker HindIII and Sph I restriction sites situated
upstream ofthe LTR. Plasmids pH2 and pH2.1 are identical to
pH1 except that the origin fragment, flanked with BamHI
Abbreviations: HIV-1, human immunodeficiency virus type 1; SV40,
simian virus 40; LTR, long terminal repeat; CAT, chloramphenicol
acetyltransferase; TAR, trans-acting responsive element; nt, nucle-
otide(s).
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linkers, was inserted in either orientation within the BamHI
site downstream of the LTR-CAT cassette. To construct
pBAH1CAT, the HindIll fragment of pH1 (containing the
origin region and HIV LTR) was cloned into the HindIII site
of pBACAT (21). Plasmid pSt5 was derived from pHIVCAT
(ref. 14; agiftofB. M. Peterlin) by insertion ofthe SV40origin,
flanked by BamHI linkers, into the BamHI site downstream
from the LTR-CAT cassette. pSt4 was derived from pSt5 by
deleting the sequences +83 to +220 relative to the transcrip-
tion start site. pStS.1 was prepared by replacing the Kpn I-Bgl
II fragment (containing the LTR region from -450 to +21) of
pStS with that ofpHi. DNA probes I, II, and III and the RNA
probe used in the RNase protection analysis are as described
by Laspia et al. (19). Probe 2 was prepared by subcloning the
HindIll fragment (+83 to +194) of pStS into M13mpl8. The
Tat expression vector pRSVtat (pBC12/RSV/t23; ref. 22) was
provided by B. R. Cullen. Plasmids pU2/-247/RA.2, encoding
a P-globin transcript, and pU2/RA.2/142, used to generate an
antisense probe (23), were provided by S. M. Lobo.
Transient Assays. DNA transfections (1.5 ,kg of reporter
gene and 1.13 pug of pRSVtat or carrier DNA per 106 COS-1
cells) were carried out using the DEAE-dextran method (24).
Run-on transcription assays were conducted at 72 hr post-
transfection using 2.5 x 107 cells per assay. Cell permeabi-
lization by digitonin and run-on transcription assays followed
the procedure of Ucker and Yamamoto (25). Reaction mix-
tures contained 1 AM UTP and 330 pCi of [a-32P]UTP (1 Ci
= 37 GBq). The RNA was purified and hybridized to slot
blots according to the protocol of Greenberg (26). Cytoplas-
mic RNA was prepared at 48 hr posttransfection (27). RNase
protection assays were carried out according to Melton et al.
(28) with 2 ,&g of RNA per assay. The quantity of plasmid
DNA in transfected cells was determined by extraction
according to Hirt (29); this was followed by alkali treatment
(1-hr incubation at 680C in 0.3 M NaOH), serial dilution, and
slot blotting onto nitrocellulose filters. The filter was probed
with sense-strand RNA probe corresponding to sequences
+1 to +83. Hybridization was quantified with the AMBIS
Beta Scan system (AMBIS Systems, San Diego). For CAT
enzyme assays, cell extracts were prepared at 48 hr post-
transfection and assayed as described (17).
RESULTS
Differential Effects of Tat on Transcriptional Initiation and
Elongation. Kao et al. (14) suggested that Tat functions as an
antiterminator without increasing the amount oftranscription
initiated from the HIV LTR, whereas Laspia et al. (19)
concluded that Tat modulates transcriptional initiation as
well as elongation. In principle, the discrepancy between
these two sets of results might reflect any of the several
differences that exist between the model systems used in
these two studies. Laspia et al. (19) introduced the HIV
LTR-reporter gene cassette into HeLa cells and HeLa/Tat
cells (human cells that stably express the Tat protein) by
infection with an adenovirus vector (17). The LTR was
derived from the U3RIII clone (20) ofthe HXB2 virus isolate.
Cells were maintained under nonreplicating conditions and
run-on analysis of transcription was conducted in isolated
nuclei. In contrast, Kao et al. (14) used recombinant plasmids
containing the reporter gene under the direction of the LTR
from the SFI1 (ARV II) virus isolate. The plasmids carried an
SV40 origin allowing them to replicate when introduced by
transfection into COS cells (monkey cells stably expressing
SV40 large tumor antigen). Tat was supplied by cotransfec-
tion of a Tat expression vector and run-on analysis was
conducted in cells permeabilized by treatment with digitonin.
We set out to discover whether the discrepant results
stemmed from inherent methodological differences between
these two systems or had a more interesting underlying
cause. As a first step, plasmid pH1, containing the pU3RIII-
CAT cassette cloned into pUC19 with a SV40 origin region
(Fig. 1), was transfected into COS cells in the presence or
absence of pRSVtat. Nascent RNA transcripts were labeled
and hybridized to nitrocellulose filters containing single-
stranded DNA probes corresponding to the sense and anti-
sense strands of the first 83 nt of the HIV leader and the next
151 nt of the CAT transcription unit (fragments I and II,
respectively; Fig. 1B). Hybridization to f3-actin was also
monitored to ensure that RNA recoveries were equivalent.
Fig. 2 shows the patterns of hybridization obtained with
RNA labeled for various periods of time in run-on transcrip-
tion assays. In the absence of Tat, hybridization to fragments
I and II was observed after 3 min of labeling. Taking into
account the greater length and uridine content of fragment II
(Fig. 1B), the data indicate that following 3 min and 6 min of
labeling the majority of transcriptional complexes were in
fragment I. By 12 min oftranscription the hybridization signal
in fragment II exceeded that in fragment I, consistent with
movement of complexes from fragment I into fragment II. In
the presence of Tat, RNA hybridizing to fragments I and II
was detected after only 1.5 min of labeling. Again, hybrid-
ization to fragment I predominated with short labeling peri-
ods but was exceeded by hybridization to fragment II with
longer labeling times, emphasizing that the shortest practical
labeling times should be used to give an accurate represen-
tation of polymerase density. The uniform increase in hy-
bridization to fragments I and II indicates that Tat has a
greater effect on transcriptional initiation than on elongation,
especially with short labeling periods. Inclusion of sarkosyl
(30) or a-amanitin demonstrated that most, if not all, of the
labeling is due to elongation ofpreviously initiated complexes
containing RNA polymerase II (not shown).
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FIG. 1. Map of HIV CAT reporter constructs. (A) Schematic
diagram of HIV CAT constructs showing the location of the SV40
origin (ori), HIV-1 nefgene sequence (striped box), LTR (open box),
CAT coding sequences (black box), and SV40 splicing and poly(A)
signals (hatched box). The orientation of the origin region, relative to
the direction of early (E) and late (L) transcription, is noted as is the
source of the viral sequences. The bacterial vector used to construct
each plasmid is also noted. (The nef region marked in the diagram
designates the portion ofthe nefgene lying upstream ofthe LTR.) (B)
Schematic diagram depicting the structure of the LTR-CAT cassette
in pSt5. The regions corresponding to probes I, 2, II, and III used in
the run-on assays are also shown.
Biochemistry: Kessler and Mathews
10020 Biochemistry: Kessler and Mathews
A
.; H -
F., '. V t
FIG. 2. Run-on transcription analysis of pH1 in the presence and
absence of Tat. COS-1 cells were mock transfected or transfected
with pHi, pRSVtat, or pH1 and pRSVtat, and run-on transcription
reactions were carried out for 1.5, 3, 6, and 12 min. Labeled RNA was
isolated and hybridized to blots containing 5 ,ug of sense (+) or
antisense (-) DNA probe corresponding to nt -18 to +83 (I), +83
to +229 (II), 13-actin, M13mpl8, and M13mpl9. The mock and
pRSVtat assays represent 12-min run-on reactions.
Although the preceding analysis was conducted under
conditions similar to those used by Kao et al. (14), the pattern
of transcription complex distribution more closely resembled
that expected from the data of Laspia et al. (19). To discover
whether the results were influenced by the structure of the
plasmid containing the HIV-CAT fusion, we next conducted
run-on transcription reactions with plasmid pStS (Fig. 1), in
which the HIV SFII-LTR is driving CAT gene expression as
in the experiments of Kao et al. (14). The distribution of
transcription complexes in the presence and absence of Tat
was compared by hybridizing the labeled RNA to four DNA
probes (I, 2, II, and III) corresponding to the first 465 nt of
the pStS mRNA (Fig. 3A). The results differed strikingly from
those obtained with pH1. With pSt5 the basal level of
transcription, signified by hybridization to the promoter
proximal fragment I, was found to be high (l10-fold higher
than with pHi) and to remain relatively unchanged in the
presence of Tat. Hybridization to the promoter distal frag-
ments 2, II, and III was significantly increased by the
presence of Tat. Thus, although Tat influences transcription
from the pH1 construct largely by increasing the frequency of
initiation events, pSt5 displayed relatively little effect on
initiation but a marked effect on processivity.
The pStS construct encodes 215 nt ofHIV leader sequences,
whereas pH1 encodes only 83 nt. The additional HIV se-
quences contained in pStS include the 3' end of the R region
and the complete U5 region (Fig. 1). Deletion of the region
between +83 and +211 (including all of probe 2 sequences)
from the pStS construct to give pSt4 did not change either the
basal level of transcription from the HIV promoter or its
response to Tat (Fig. 3A). The basal and Tat-stimulated levels
of transcription, as measured by the hybridization to fragment
I, were very similar for both templates, suggesting that Tat has
little or no effect on transcriptional initiation. Hybridization to
the promoter distal regions (fragments II and III) was signif-
icantly increased with both templates, implying that the pri-
mary effect of Tat on transcription with these constructs is at
the level of elongation.
The U3 regions of pH1 and pStS are about 10% divergent
in sequence (31). Since this region contains the HIV pro-
moter, we considered the possibility that the transcriptional
differences between pH1 and pSt5 were due to this sequence
variation. The U3 region of pSt5 was therefore replaced with
that ofpH1 to give plasmid pSt5.1 (Fig. 1), and the transcrip-
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FIG. 3. Influence of LTR sequences from two viral isolates on
transcription. (A) COS-1 cells were transfected with pSt5 or pSt4 in
the presence or absence of pRSVtat, and run-on transcripts were
hybridized as in Fig. 2. The regions corresponding to probes I, 2, II,
and III and their U contents are noted in Fig. 1. The sequences
contained within the region of probe 2 and the polylinker (hatched
box) are absent from pSt4. (B) Run-on transcription analysis of pSt5
and pSt5.1. COS-1 cells were transfected with pSt5 and pSt5.1 in the
presence and absence of pRSVtat, and run-on assays were carried
out as described above.
tional activities of pSt5.1 and pSt5 were compared. Similar
patterns of run-on transcription were obtained with these
plasmids in the presence and absence of Tat (Fig. 3B). We
conclude that the different transcriptional activities of pH1
and pStS are not due to differences in their LTRs, either
upstream or downstream of the transcription start site.
The SV40 Origin Region Influences Transcription from the
HIV LTR. Since the different transcriptional activities ofpH1
and pStS are not due to differences in HIV sequences
contained within the promoter or leader regions, the discrep-
ancy must be due to HIV sequences upstream of the U3
region (both constructs were prepared from the 3' LTR and
contain part of the nefgene) or to sequences contained within
their respective vectors. The two plasmids differ in the vector
used in their construction and in the position and orientation
of the SV40 origin region relative to the reporter gene (Fig.
1). Three new constructs were prepared to determine which
of these differences could account for the different transcrip-
tional activities of pH1 and pStS (Fig. 1). The first construct,
pH2, is identical to pH1 with the exception that the SV40
origin has been moved to the downstream location that it
occupies in pSt5 and with the same orientation. In the second
construct, pH2.1, the origin region was left in the same
location as in pH2 but was inverted to match its orientation
in pH1. The third construct, pBAH1CAT, is identical to pH1
with respect to the position and orientation ofthe SV40 origin
and HIV sequences, but the vector is the pBR-based plasmid
pBA (21). When the transcriptional activities and the re-
sponses of each of these constructs to Tat were measured by
the run-on assay, we found that pBAH1CAT behaved like
pH1 and that pH2 and pH2.1 behaved like pSt5 (data not
shown). Therefore, the different transcriptional activities of
Proc. Natl. Acad. Sci. USA 88 (1991)
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pH1 and pSt5 are due to the position, but not orientation, of
the SV40 origin region relative to the HIV LTR.
RNase protection analysis of cytoplasmic HIV LTR-
directed RNA confirmed these conclusions. With an antisense
probe extending from +83 to -117, two classes of protected
fragments were anticipated: a series of short fragments, 55-59
nt in length, presumably resulting from premature termination
of transcription, and a longer fragment (83 nt) representing
full-length mRNA (14, 19, 32). In the absence of Tat, pH1 and
pBAH1CAT gave rise to very little RNA (Fig. 4A, lanes 1 and
5). The protected species corresponding to the long and short
RNA populations were observed in roughly equal abundance.
In the presence of Tat little change was observed in the
quantity of short RNAs, but the abundance of long transcripts
was greatly increased (lanes 2 and 6). By contrast, pH2 and
pSt4 generated large amounts of short transcripts in the
absence ofTat (lanes 3 and 7). Full-length RNA was observed,
but as a minor population of the protected RNA. In the
presence of Tat, these two constructs gave rise to large
amounts ofthe full-length RNA (lanes 4 and 8). Similar results
were obtained with pSt5 (data not shown), confirming the
observations of Kao et al. (14). Although the quantity of short
transcripts was reduced, the reduction did not appear to be
sufficient to account for the increase in full-length RNA and
was not observed consistently (see Fig. 4C). RNA transcribed
from pH2.1 in the presence and absence ofTat (Fig. 4C, lanes
1 and 2) was similar to that transcribed from pSt4 (lanes 3 and
4). Thus, the positioning of the SV40 origin upstream of the
LTR gives rise to a lower basal level of HIV-promoted
transcripts and allows for a large effect of Tat on cytoplasmic
RNA accumulation. Corresponding results were obtained by
measurement of CAT enzyme activity (Table 1).
We also considered the possibility that the different quan-
tities of cytoplasmic RNA observed following transfection of
these plasmids were the result of differences in the efficiency
of transfection or replication of the plasmid DNA. To control
for transfection efficiency and RNA recovery, a plasmid
containing 3-globin sequences under the direction of the U2
snRNA promoter was included in each transfection. As
shown in Fig. 4B, the differences in transfection efficiency,
reflected in differences in the amount of protected f3-globin
probe, cannot account for the observed differences in HIV
LTR-directed transcription. To measure the relative quantity
of plasmid present at the time ofRNA extraction, DNA was
isolated from the transfected cells and quantified by hybrid-
ization. From the data ofTable 1 it is apparent that there were
variations in the amount ofDNA, but the differences (2-fold
overall) were too small to account for the differences ob-
served at the level of cytoplasmic RNA.
DISCUSSION
In a transient expression system, the HIV-1 transactivator
protein Tat is capable of activating transcription from the
HIV-1 LTR by increasing the rate of transcriptional initiation
and by increasing the efficiency of transcriptional elongation.
The relative extent to which it performs each ofthese functions
is determined by the basal level ofLTR-directed transcription.
If the basal level of transcription is high, Tat functions pri-
marily to increase the elongation rate, whereas if the basal
level is low Tat primarily increases the rate of initiation. This
finding is in accord with previous studies in which we utilized
recombinant adenovirus containing the HIV LTR-CAT cas-
sette to study Tat-mediated activation of HIV transcription.
Tat increased the rate of transcriptional initiation and stabi-
lized elongation in HeLa cells infected with the virus but only
stabilized elongation when transcription was carried out in the
presence of the general transcriptional activator ElA (19, 33).
These observations may help to reconcile the results of
Kao et al. (14), who concluded that Tat acts as an antiter-
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FIG. 4. Effect of vector and SV40 origin sequences on HIV
LTR-directed RNA expression. (A) RNase protection analysis of
cytoplasmic HIVCAT RNA following transfection of COS-1 cells
with pH1 (lanes 1 and 2), pH2 (lanes 3 and 4), pI3AH1CAT (lanes 5
and 6), or pSt4 (lanes 7 and 8) or without an LTR-CAT plasmid (lane
9) in the presence (lanes 2, 4, 6, 8, and 9) or absence (lanes 1, 3, 5,
and 7) of pRSVtat. Lane M contains pBR322/Hpa II markers.
Locations of the long and short transcripts are marked. (B) RNase
protection analysis of .8-globin transcripts present in the cytoplasmic
RNA preparations used in A. Plasmid pU2/-247/RA.2 was cotrans-
fected with the HIVCAT reporter constructs and RNase protection
analysis was carried out using a riboprobe transcribed from EcoRI-
digested pU2/RA.2/142. A 142-nt fragment is protected. (C) RNase
protection analysis of cytoplasmic HIVCAT RNA following trans-
fection of COS-1 cells with pH2.1 (lanes 1 and 2) or pSt4 (lanes 3 and
4) or without a LTR-CAT plasmid (lane 5) in the presence (lanes 2,
4, and 5) or absence (lanes 1 and 3) of pRSVtat. Lane M contains
pBR322/Hpa II markers. Locations of the long and short transcripts
are noted. (D) Schematic diagram of the mapping strategy depicting
the probe, RNA transcripts, and protected fragments.
minator to increase transcriptional elongation, with results
from our laboratory indicating that Tat also acts to increase
the rate of initiation (19). The most likely explanation would
be that Kao et al. (14) studied Tat transactivation in the
context of a high basal level of HIV-directed transcription,
whereas Laspia et al. (19) examined transactivation under
conditions where the promoter exhibited a low basal level of
Biochemistry: Kessler and Mathews
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Table 1. Quantitation of plasmid DNA and HIV-directed CAT
activity in transfected cells
DNA level* CAT activityt
Without Tat With Tat Without Tat With Tat
pH1 149 99 12 2300
pBAH1CAT 130 74 26 1120
pH2 166 160 312 6000
pSt4 202 106 120 6720
pSt4- 2
None§ 5
*Values represent the standardized cpm hybridizing to two dilutions
of blotted DNA.
tPercent conversion of chloramphenicol substrate to its acetylated
forms.
*Control, not alkali-treated.
§DNA extracted from cells transfected with pRSVtat only.
transcription. Consistent with this view, Kao et al. (14) used
a plasmid with the SV40 origin downstream from the HIV-
reporter gene cassette for their analysis of RNA accumula-
tion. Unfortunately for this simple explanation, the plasmid
used in their run-on transcription analysis contained the SV40
origin region upstream from the HIV LTR. This construct is
analogous to pH1, which displayed low basal level of activity
in our study and which therefore would be expected to exhibit
increased initiation in the presence of Tat. However, direct
comparison is not possible because the distance of the origin
region from the LTR and the size of the SV40 fragment
containing the origin sequences differed from pH1, and it is
possible that these factors change the influence of the origin
region on basal transcription levels.
It is not clear why the SV40 origin region influences
transcription from the HIV LTR. Since the origin region
contains, in addition to sequences directingDNA replication,
promoter elements involved in the regulation ofearly and late
viral gene expression, its effect could be due to occlusion of
the HIV promoter by transcription from the origin region.
This explanation seems unlikely, however, since RNA tran-
scripts containing sequences 5' to the LTR start site were
detected only as a minor population with plasmids expressing
elevated basal levels of transcription, pH2 and pSt4, and not
with plasmids expressing low basal levels (result not shown).
An alternative explanation is that the replication process
influences transcription from the HIV promoter, but to
different degrees depending on the distance of the origin of
replication from the promoter. In several instances, replica-
tion has been shown to activate transcription (34-38) and the
HIV LTR may belong to this class of promoters (N. Proud-
foot and J. Monks, personal communication).
The transition from viral latency to growth, as well as from
noncytopathic to cytopathic infection, appears to require the
coordinated and sequential expression of the viral regulatory
and structural proteins (39-41). Viral transcriptional rates
directly influence this pathway (40). Activation of the HIV
promoter as a result ofDNA replication may explain, at least
in part, why nonresting T cells are permissive for HIV-1
infection, whereas Go cells are not (42). Interestingly, analysis
of retroviral replication in resting and actively growing cells
revealed the proviral DNA to be integrated only in cellular
DNA replicated during infection (43). Whether cellular origin
regions are preferred sites for viral integration is unknown.
However, if the effect of the SV40 origin region on HIV gene
expression is typical, viral integration near a cellular origin
may contribute significantly to the pathobiology of the virus.
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